The diabetes risk score -: A practical tool to predict type 2 diabetes risk

被引:1333
作者
Lindström, J
Tuomilehto, J
机构
[1] Natl Publ Hlth Inst, Diabet & Genet Epidemiol Unit, Dept Epidemiol & Hlth Promot, SF-00300 Helsinki, Finland
[2] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland
关键词
D O I
10.2337/diacare.26.3.725
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Interventions to prevent type 2 diabetes should be directed toward individuals at increased risk for the disease. To identify such individuals without laboratory tests, we developed the Diabetes Risk Score. Research Design and Methods-A random population sample of 35- to 64-year-old men and women with no antidiabetic drug treatment at baseline were followed for 10 years. New cases of drug-treated type 2 diabetes were ascertained from the National Drug Registry. Multivariate logistic regression model coefficients were used to assign each variable category a score. The Diabetes Risk Score was composed as the sum of these individual scores. The validity of the score was tested in an independent population survey performed in 1992 with prospective follow-up for 5 years. Results-Age, BMI, waist circumference, history of antihypertensive drug treatment and high blood glucose, physical activity, and daily consumption of fruits, berries, or vegetables were selected as categorical variables. Complete baseline risk data were found in 4,435 subjects with 182 incident cases of diabetes. The Diabetes Risk Score value varied from 0 to 20. To predict drug-treated diabetes, the score value greater than or equal to9 had sensitivity of 0.78 and 0.81, specificity of 0.77 and 0.76, and positive predictive value of 0.13 and 0.05 in the 1987 and 1992 cohorts, respectively. Conclusions-The Diabetes Risk Score is a simple, fast, inexpensive, noninvasive, and reliable tool to identify individuals at high risk for type 2 diabetes.
引用
收藏
页码:725 / 731
页数:7
相关论文
共 38 条
  • [1] ALBERTI KGM, 1999, DEFINITION DIAGNOS 1
  • [2] Association AD, 2002, DIABETES CARE, V25, ps21, DOI [DOI 10.2337/DIACARE.25.2007.S21, 10.2337/diacare.25.2007.S21]
  • [3] Performance at a predictive model to identity undiagnosed diabetes in a health care setting
    Baan, CA
    Ruige, JB
    Stolk, RP
    Witteman, JCM
    Dekker, JM
    Heine, RJ
    Feskens, EJM
    [J]. DIABETES CARE, 1999, 22 (02) : 213 - 219
  • [4] Borch-Johnsen K, 1998, BMJ-BRIT MED J, V317, P371
  • [5] Borch-Johnsen K, 1999, LANCET, V354, P617
  • [6] Glucose tolerance and cardiovascular mortality -: Comparison of fasting and 2-hour diagnostic criteria
    Borch-Johnsen, K
    Neil, A
    Balkau, B
    Larsen, S
    Nissinen, A
    Pekkanen, J
    Tuomilehto, J
    Jousilahti, P
    Lindstrom, J
    Pyörälä, M
    Pyörälä, K
    Eschwege, E
    Gallus, G
    Garancini, MP
    Bouter, LM
    Dekker, JM
    Heine, RJ
    Nijpels, HG
    Stehouwer, CDA
    Feskens, EJM
    Kromhout, D
    Peltonen, M
    Pajak, A
    Eriksson, J
    Qiao, Q
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (03) : 397 - 405
  • [7] Gestational diabetes: Risk or myth?
    Buchanan, TA
    Kjos, SL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (06) : 1854 - 1857
  • [8] DIETARY FACTORS DETERMINING DIABETES AND IMPAIRED GLUCOSE-TOLERANCE - A 20-YEAR FOLLOW-UP OF THE FINNISH AND DUTCH COHORTS OF THE 7-COUNTRIES STUDY
    FESKENS, EJM
    VIRTANEN, SM
    RASANEN, L
    TUOMILEHTO, J
    STENGARD, J
    PEKKANEN, J
    NISSINEN, A
    KROMHOUT, D
    [J]. DIABETES CARE, 1995, 18 (08) : 1104 - 1112
  • [9] Feskens EJM, 1999, NUTR METAB CARDIOVAS, V9, P87
  • [10] Finnish Diabetes Association, 2001, DEV PROGR PREV CAR D